Molecular biology of the 2-oxo-acid dehydrogenase complexes and anti-mitochondrial antibodies.

M. Eric Gershwin, M. Rowley, P. A. Davis, Patrick S Leung, R. Coppel, I. R. Mackay

Research output: Contribution to journalArticlepeer-review

34 Scopus citations


The confluence of molecular biology and clinical medicine has provided new and valuable insights in PBC. Our understanding of the immunobiology of PBC has changed dramatically using this new technology. It is now possible to explicitly define mitochondrial autoantigens and examine recognition sites, by using autoantibodies, at the primary sequence level. In addition, cloned antigens have been developed to reliably assay for presence of autoantibodies; the use of cloned recombinant antigens should replace that of traditional immunofluorescence for AMA assay. It is also now possible to begin the task of defining the role of T cells in the immunopathology of PBC and exploring the issue of whether immunotherapy is possible. Finally, there is increasing evidence that PDC-E2 is located on the cell membrane of biliary epithelial cells. The mechanism for this expression remains to be studied. The explosion of data in PBC is an example of the serendipity and synergy brought about by application of new techniques to investigate old problems.

Original languageEnglish (US)
Pages (from-to)47-61
Number of pages15
JournalProgress in Liver Diseases
StatePublished - 1992

ASJC Scopus subject areas

  • Hepatology


Dive into the research topics of 'Molecular biology of the 2-oxo-acid dehydrogenase complexes and anti-mitochondrial antibodies.'. Together they form a unique fingerprint.

Cite this